A Review of Red Blood Cell Membrane Camouflaged Nanoparticles (Anti-Tumor)

Due to their characteristics of biocompatibility, biodegradability, and extended circulating half-life, erythrocytes, also known as red blood cells or RBCs, are the most prevalent circulating cells in the blood and have found extensive application in drug delivery systems (DDS). In light of this, an erythrocyte-based “camouflage” membranes creates a platform for nanoparticles that combines the benefits of native erythrocyte membranes with nanomaterial-based ones. When administered intraperitoneally to animal models, the coated In order to accomplish long-term circulation, nanoparticles mimic RBCs and interact with their surroundings. The erythrocyte membrane-coated nano-cores biomimetic platform is reviewed in this paper with an emphasis on the coating mechanism, preparation techniques, and verification. techniques, as well as the newest anti-tumor software. Lastly, further erythrocyte functional alterations membranes and efforts to combine the characteristics of several cell membranes on their surface are examined. establishing a framework to encourage in-depth study of multifunctional nano-biomimetic systems